SEPTIN5: A Potential Drug Target and Biomarker (G5413)

Target Name: SEPTIN5

NCBI ID: G5413

SEPTIN5

SEPTIN5: A Potential Drug Target and Biomarker

SEPTIN5 is a protein that belongs to the SEPIN family, which is known for its role in cell signaling and structure. It is a 5-dimensional protein that consists of four subunits that are held together by disulfide bonds. SEPTIN5 is expressed in various tissues and cells throughout the body, including the heart, lungs, and intestines.

SEPTIN5 has been shown to play a role in various physiological processes in the body, including cell signaling, cytoskeletal organization, and inflammation. It is involved in the regulation of cell proliferation, differentiation, and survival, as well as in the regulation of cellular signaling pathways that are important for various cellular processes, including cell growth, apoptosis, and inflammation.

SEPTIN5 has also been shown to be a potential drug target. Its role in various physiological processes makes it an attractive target for small molecule inhibitors, which can be used to treat various diseases. SEPTIN5 has also been shown to be a biomarker for various diseases, including cancer, neurodegenerative diseases, and inflammatory diseases.

One of the key challenges in targeting SEPTIN5 is its high stability. SEPTIN5 has a molecular weight of 170 kDa and a calculated pI of 6.3, which makes it a difficult target for small molecules. Additionally, SEPTIN5 is a protein that is expressed in a variety of tissues and cells throughout the body, which makes it difficult to selectively target it.

To overcome these challenges, researchers have developed various strategies to target SEPTIN5. One approach is to use inhibitors that are specific for SEPTIN5, but not for its other subunits. This approach is based on the idea that if an inhibitor is able to inhibit the activity of SEPTIN5, it should not have any impact on the activity of its other subunits.

Another approach is to use inhibitors that are specific for SEPTIN5 subunits that are involved in certain cellular processes. For example, some researchers have used inhibitors that target the N-terminal subunit of SEPTIN5 to prevent it from participating in the regulation of cellular signaling pathways.

In addition to inhibitors, researchers have also used other approaches to target SEPTIN5. One approach is to use antibodies that are specific for SEPTIN5, but not for its other subunits. This approach is based on the idea that if an antibody is able to bind to SEPTIN5, it should not have any impact on the activity of its other subunits.

Another approach is to use small molecules that are specific for SEPTIN5, but not for its other subunits. This approach is based on the idea that if a small molecule is able to bind to SEPTIN5, it should not have any impact on the activity of its other subunits.

Overall, SEPTIN5 is a protein that has great potential as a drug target and biomarker. Its role in various physiological processes makes it an attractive target for small molecule inhibitors, and its high stability and expression in various tissues and cells makes it difficult to target. However, by using various strategies, including inhibitors, antibodies, and small molecules, researchers may be able to selectively target SEPTIN5 and its subunits and use it for the treatment of various diseases.

Protein Name: Septin 5

Functions: Filament-forming cytoskeletal GTPase (By similarity). May play a role in cytokinesis (Potential). May play a role in platelet secretion (By similarity)

The "SEPTIN5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEPTIN5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets